Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Pigment and tattoo removal

Nano or picosecond laser?

    • Congress Reports
    • Dermatology and venereology
    • RX
  • 2 minute read

Previous laser treatments of tattoos were often insufficient. Picosecond lasers produce better results than nanosecond lasers, and the efficacy is also very good for pigment lesions.

The development of lasers with a pulse duration in the picosecond range is a milestone in laser technology. Combining high efficacy with a low rate of side effects, picosecond lasers have great future potential, concludes a review published in 2019 [1]. In particular, it represents a major advance in the areas of tattoo removal and treatment of benign pigmentary lesions, and its use in other indications is currently being explored.

Alma PICO CLEAR is one of the market leaders

With a pulse duration of 300-350 picoseconds (ps), Alma PICO CLEAR has the shortest pulse duration on the market. In addition to removal of pigmented lesions and dark colored tattoos, this laser device can also be used for skin rejuvenation and other indications. It is well known that a shorter pulse duration leads to better effects due to a higher explosive force on the pigments. The speaker demonstrated this impressively with a concrete comparison of the results between the ruby laser SINON II (pulse duration 20 ns) and the Alma PICO CLEAR (pulse duration 300-350 ps) [2].

Efforts are underway to make this cutting-edge, high-performance device available to the local market, as Dr. Uwe Schmidt, head of clinical trials and training at Alma Lasers GmbH, announced during the luncheon lecture at the SGML annual meeting. His company regularly organizes workshops at which the new laser devices are presented (e.g. at the Smartaging Swiss Academy) [3].

Quantum leap for the field of tattoo removal  

The treatment of tattoos with nanosecond lasers often leads to unsatisfactory results. Scarring and other negative long-term consequences are not uncommon. Picosecond lasers, on the other hand, enable precise and safe tattoo removal [4]. The speaker demonstrated this with a case study. The ruby laser resulted in blistering and scarring despite the use of low energy, which was not the case with the picosecond laser.

 

 

There is an increasing demand for tattoo removal. In the 1990s, tattoos were trendy as an expression of a facet of identity or simply as body art, especially among young people. As they age, most people want to part with these relics of past phases of their lives. About half of all tattooed people later wish to have a tattoo removed. In addition to the subjective change in perception, unpleasant physical side effects or stigmatization can also be a motivating factor. A failed tattoo removal that aggravates rather than alleviates the disfigurement problem is very distressing for those affected. The use of picosecond lasers ensures more effective treatment with fewer side effects than previous lasers.

Source: SGML Lasers&Procedures, January 17, 2019, Zurich

 

Literature:

  1. Torbeck RL, et al: Evolution of the Picosecond Laser: A Review of Literature. Dermatol Surg 2019; 45(2): 183-194.
  2. Slide presentation Dr. Uwe Schidt, ALMA LASERS GmbH, SGML Lasers&Procedures, 17.01.2019, Zurich.
  3. Smartaging Swiss Academy, https://smartaging-swiss.academy/de/kurse/firmenevent/95-almalasers-exklusiv-wokshop-picosekundenlaser).
  4. Ibrahim O, et al: Picosecond Lasers. Do the data support the claims? Advances in Cosmetic Surgery 2018; 1: 175-183.

 

 

DERMATOLOGIE PRAXIS 2019; 29(1): 31

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • pico clear
  • Pigment
  • pigment lesion
  • pulse duration
  • tattoo removal
Previous Article
  • Supplements in sport

Creatine, protein & Co. – what makes sense?

  • Education
  • General Internal Medicine
  • Nutrition
  • RX
  • Sports Medicine
View Post
Next Article
  • Onychomycoses

Still a therapeutic challenge

  • Dermatology and venereology
  • Education
  • Infectiology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 12 min
  • Cancer prevention

Constant dripping – alcohol and cancer

    • CME continuing education
    • General Internal Medicine
    • Oncology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Steatotic liver disease

GLP-1RA in MASH – what’s new?

    • Congress Reports
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Chronic pruritus: “Tour d'horizon”

Focus on new anti-inflammatory therapeutic approaches

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Multiple sclerosis

Unexpected side effects when switching from natalizumab to a biosimilar

    • Education
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 3 min
  • Immunotherapy

Subcutaneously or intravenously?

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 4 min
  • Work-related asthma

When the job leads to exacerbations

    • Allergology and clinical immunology
    • Education
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 0 min
  • Inoperable NSCLC

Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 3 min
  • De-escalation strategies

De-escalation strategies – less is more

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Constant dripping – alcohol and cancer
  • 2
    Hurdles to pain treatment for autistic patients
  • 3
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 4
    Treatment of comorbidities in older people
  • 5
    New nomenclature for non-alcoholic fatty liver disease

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.